OCTOBER ISSUE | #ResearchHighlight Lenvatinib plus EGFR inhibition for #livercancer https://t.co/2OftmThpx2 https://t.co/rsAtCmj5wv
New article: Lenvatinib plus EGFR inhibition for liver cancer https://t.co/LbsK2OKxkP #livercancer #oncology https://t.co/1E8LLGXmN7
RT @NatRevGastroHep: New content online: Lenvatinib plus EGFR inhibition for liver cancer https://t.co/cMsB9JtziI https://t.co/z5f272tV7R
RT @NatRevGastroHep: New content online: Lenvatinib plus EGFR inhibition for liver cancer https://t.co/cMsB9JtziI https://t.co/z5f272tV7R
RT @NatRevGastroHep: New content online: Lenvatinib plus EGFR inhibition for liver cancer https://t.co/cMsB9JtziI https://t.co/z5f272tV7R
RT @NatRevGastroHep: New content online: Lenvatinib plus EGFR inhibition for liver cancer https://t.co/cMsB9JtziI https://t.co/z5f272tV7R
New content online: Lenvatinib plus EGFR inhibition for liver cancer https://t.co/cMsB9JtziI https://t.co/z5f272tV7R